QULIPTA Commercial United States

Ad Creative: QULIPTA Girls Trip Click OLV 30 Core Copy Updates

QULIPTA QULIPTA Girls Trip Click OLV 30 Core Copy Updates Ad Commercial Brand Imagery Photoshoot 0
QULIPTA QULIPTA Girls Trip Click OLV 30 Core Copy Updates Ad Commercial Brand Imagery Photoshoot 1
QULIPTA QULIPTA Girls Trip Click OLV 30 Core Copy Updates Ad Commercial Brand Imagery Photoshoot 2

QULIPTA Ad Profile

  • Advertising Market: United States
  • Advertiser Industry: Health
  • Advertiser Category: Migraine
  • Ad Launch Date: 2025-01-22
  • Ad Format: 30 seconds
  • Ad Description: QULIPTA Girls Trip Click OLV 30 Core Copy Updates

QULIPTA Ad Transcript

Creative storyline based on voiceover.

  • 00:00 - how did I ever miss this before you were
  • 00:02 - preventing Migraine with cipto you'll
  • 00:04 - never truly forget migraine but cipto
  • 00:06 - reduces attacks making more zero
  • 00:07 - migraine days possible it's approved to
  • 00:09 - prevent migraine to help give you that
  • 00:11 - forget you get migraine feeling don't
  • 00:12 - take if allergic to cipta get help right
  • 00:15 - away for serious allergic reactions like
  • 00:17 - trouble breathing face lip or tongue
  • 00:18 - swelling itching or rash which may occur
  • 00:20 - when taking cypa or days after common
  • 00:23 - side effects include nausea constipation
  • 00:24 - and sleepiness learn how abvi could help
  • 00:26 - you save cipta the forget you get
  • 00:29 - migraine medicine

QULIPTA Ad Reach

Audience reach based on YouTube views benchmarked against Market, Industry and Category.

  Medium vs. United States

  Medium vs. Health

  Medium vs. Migraine

QULIPTA Ad Favorability

Creative favorability based on YouTube likes benchmarked against Market, Industry and Category.

  No Data

  No Data

  No Data

QULIPTA Ad Engagement

Audience engagement based on YouTube comments benchmarked against Market, Industry and Category.

  No Data

  No Data

  No Data

QULIPTA Ad Collections

Check out similar ads from competitors.